Robert Wasserman
Stock Analyst at Benchmark Co.
(4.15)
# 1,537
Out of 4,463 analysts
230
Total ratings
45.1%
Success rate
10.1%
Average return
Main Sectors:
Stocks Rated by Robert Wasserman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRLB Proto Labs | Maintained: Buy | $70 → $91 | $76.98 | +18.21% | 15 | Jul 2, 2026 | |
| TECH Bio-Techne | Downgraded: Hold | n/a | $70.81 | - | 18 | Jun 30, 2026 | |
| XOMA XOMA Royalty | Downgraded: Hold | n/a | $42.58 | - | 4 | May 22, 2026 | |
| ITGR Integer Holdings | Upgraded: Buy | $140 → $95 | $95.04 | -0.04% | 18 | Feb 20, 2026 | |
| HALO Halozyme Therapeutics | Maintained: Buy | $90 | $78.36 | +14.85% | 22 | Feb 19, 2026 | |
| TLV: KMDA Kamada Ltd. | Maintained: Buy | ILA 4,478 | $2,255.00 | +98.59% | 4 | Jan 8, 2026 | |
| LGND Ligand Pharmaceuticals | Maintained: Buy | $220 | $311.67 | -29.41% | 19 | Dec 10, 2025 | |
| CDXS Codexis | Maintained: Hold | n/a | $2.42 | - | 16 | Nov 14, 2025 | |
| OABI OmniAb | Maintained: Buy | $6 → $4 | $2.43 | +64.95% | 11 | Nov 6, 2025 | |
| INTS Intensity Therapeutics | Maintained: Buy | $38 | $4.15 | +803.61% | 7 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $141.94 | - | 10 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $8.10 | - | 8 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $3.65 | +36.99% | 8 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $28.44 | +5.49% | 10 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $8.15 | +47.24% | 20 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $1.56 | +92.31% | 8 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 | $5.48 | n/a | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $524.36 | n/a | 7 | Oct 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $197.43 | n/a | 5 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.97 | n/a | 4 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $80 | $2.15 | n/a | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $3.09 | n/a | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.12 | n/a | 3 | Jan 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $0.537 | n/a | 1 | Jan 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4.2 | $1.61 | n/a | 1 | Oct 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $3.06 | n/a | 1 | Aug 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $2.35 | n/a | 2 | Jan 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.25 | $1.06 | n/a | 1 | Nov 7, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $3.45 | n/a | 1 | Mar 12, 2013 |
Proto Labs
Jul 2, 2026
Maintained: Buy
Price Target: $70 → $91
Current: $76.98
Upside: +18.21%
Bio-Techne
Jun 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $70.81
Upside: -
XOMA Royalty
May 22, 2026
Downgraded: Hold
Price Target: n/a
Current: $42.58
Upside: -
Integer Holdings
Feb 20, 2026
Upgraded: Buy
Price Target: $140 → $95
Current: $95.04
Upside: -0.04%
Halozyme Therapeutics
Feb 19, 2026
Maintained: Buy
Price Target: $90
Current: $78.36
Upside: +14.85%
Kamada Ltd.
Jan 8, 2026
Maintained: Buy
Price Target: ILA 4,478
Current: $2,255.00
Upside: +98.59%
Ligand Pharmaceuticals
Dec 10, 2025
Maintained: Buy
Price Target: $220
Current: $311.67
Upside: -29.41%
Codexis
Nov 14, 2025
Maintained: Hold
Price Target: n/a
Current: $2.42
Upside: -
OmniAb
Nov 6, 2025
Maintained: Buy
Price Target: $6 → $4
Current: $2.43
Upside: +64.95%
Intensity Therapeutics
Oct 31, 2025
Maintained: Buy
Price Target: $38
Current: $4.15
Upside: +803.61%
Oct 29, 2025
Maintained: Hold
Price Target: n/a
Current: $141.94
Upside: -
Aug 13, 2025
Maintained: Hold
Price Target: n/a
Current: $8.10
Upside: -
Aug 12, 2025
Maintained: Buy
Price Target: $5
Current: $3.65
Upside: +36.99%
Aug 11, 2025
Maintained: Buy
Price Target: $30
Current: $28.44
Upside: +5.49%
Aug 8, 2025
Maintained: Buy
Price Target: $12
Current: $8.15
Upside: +47.24%
Jul 31, 2025
Maintained: Buy
Price Target: $3
Current: $1.56
Upside: +92.31%
Feb 3, 2025
Downgraded: Hold
Price Target: $4
Current: $5.48
Upside: n/a
Oct 26, 2023
Maintained: Hold
Price Target: n/a
Current: $524.36
Upside: n/a
Oct 25, 2023
Maintained: Hold
Price Target: n/a
Current: $197.43
Upside: n/a
Sep 15, 2023
Maintained: Hold
Price Target: n/a
Current: $5.97
Upside: n/a
Apr 4, 2023
Maintained: Buy
Price Target: $9 → $80
Current: $2.15
Upside: n/a
Feb 24, 2021
Reiterated: Buy
Price Target: $9
Current: $3.09
Upside: n/a
Jan 24, 2020
Rated: Hold
Price Target: n/a
Current: $1.12
Upside: n/a
Jan 9, 2019
Initiated Coverage: Buy
Price Target: $11
Current: $0.537
Upside: n/a
Oct 17, 2018
Initiated Coverage: Buy
Price Target: $4.2
Current: $1.61
Upside: n/a
Aug 28, 2018
Initiated Coverage: Buy
Price Target: $46
Current: $3.06
Upside: n/a
Jan 29, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $2.35
Upside: n/a
Nov 7, 2013
Initiated Coverage: Buy
Price Target: $5.25
Current: $1.06
Upside: n/a
Mar 12, 2013
Reiterated: Buy
Price Target: $6
Current: $3.45
Upside: n/a